<DOC>
	<DOCNO>NCT02394600</DOCNO>
	<brief_summary>This pilot study Phase IV , single center , placebo-controlled , parallel study design conduct use Environmental Exposure Unit ( EEU ) . The study aim determine whether benefit Grastek® treatment birch-pollen induce allergic rhinoconjunctivitis . Grastek® Health Canada FDA approve sublingual immunotherapy ( SLIT ) treatment grass-pollen induced allergic rhinoconjunctivitis . The EEU provide close environment participant expose predetermine , control , constant level airborne pollen . 96 participant complete study either receive Grastek® placebo 1:1 ratio . The study consist screen visit , pre-treatment pollen exposure visit , 60 day treatment Grastek® placebo , two treatment visit follow-up pollen exposure visit .</brief_summary>
	<brief_title>The Impact Grass SLIT Treatment Birch Pollen Induced Allergic Rhinitis - Pilot Evaluation</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<criteria>1 . Participant demonstrate understand provide appropriately sign date informed consent . 2 . Male Female , 18 65 year age , time Screening visit . 3 . Participant history least moderate allergic rhinoconjunctivitis due hypersensitivity birch pollen minimum 2 year . 4 . Participant respond birch pollen timothy grass pollen standard skin prick test administer Screening visit . A positive test define wheal diameter least 5mm large negative control ( normal saline ) wheal . A historical skinprick test perform within threehundred sixtyfive ( 365 ) day one ( 1 ) year site accept lieu perform new skin prick test . 5 . Participant understands willing , able likely comply study procedure restriction . 6 . Participant , female , negative urine pregnancy test Visit 1 willing use medically acceptable form birth control . Acceptable method birth control study include : oral , patch , intravaginal hormonal contraceptive Norplant System® DepoProvera® IUD double barrier method abstinence surgically sterile female ( hysterectomy tubal ligation ) &gt; 1 year postmenopausal females sex partner partner vasectomy ( &gt; 3 month ) 7 . Participant healthy determine prestudy medical history , physical examination vital sign . 8 . Participant able read , comprehend , record information English . 9 . Participant serum specific IgE level birch timothy grass ≥0.7 ku/L . 1 . Has significant current nasal ocular symptom study doctor associate perennial allergic nonallergic rhinitis . 2 . Female participant pregnant lactating . 3 . Has history illness , opinion study investigator , might confound result study pose additional risk participant participation study . This include clinically relevant medical surgical history presence respiratory disease ( exception make asthma allergic rhinitis define exclusion criterion ) , gastrointestinal , renal , hepatic , hematological , lymphatic , neurological , cardiovascular , psychiatric , musculoskeletal , immunological , dermatological , connective tissue diseases disorder , history malignancy within past 5 year , exception nonmelanoma skin cancer . 4 . Has significant abnormality find physical exam determine investigator . 5 . Has current medical history significant pulmonary disease and/or active asthma require daily drug therapy . Mild , intermittent asthma permit ( manage short act betaagonist le 3 time per week ) . Isolated exerciseinduced bronchospasm also permit . 6 . Has receive investigational drug within last thirty ( 30 ) day . 7 . Has use immunotherapy contain grass birch within last 3 year . 8 . Has significant nasal polyp , nasal septal perforation , nasal tract malformation note physical exam . 9 . Administration adrenaline ( epinephrine ) contraindicate ( e.g . participant acute chronic symptomatic coronary heart disease concomitant betablocker therapy ) . 10 . Is unlikely cooperate requirement study include ability communicate investigator appropriately .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>rhinitis</keyword>
	<keyword>allergy</keyword>
</DOC>